Bank of Nova Scotia
ALXO icon

Bank of Nova Scotia’s ALX Oncology ALXO Stock Holding History

Bank of Nova Scotia’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Hold
105,858
– – ﹤0.01% 1024
2025
Q4 		$120K Hold
105,858
– – ﹤0.01% 1058
2025
Q3 		$194K Hold
105,858
– – ﹤0.01% 984
2025
Q2 		$43.9K Hold
105,858
– – ﹤0.01% 988
2025
Q1 		$66K Buy
105,858
+552
+0.5% +$663 ﹤0.01% 984
2024
Q4 		$176K Buy
+105,306
New +$162K ﹤0.01% 962

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Bank of Nova Scotia's ALXO Position: Q1 2026 in Review

Bank of Nova Scotia held its ALX Oncology (ALXO) position steady in Q1 2026 at 105,858 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Bank of Nova Scotia first reported a position in ALXO in Q4 2024 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Bank of Nova Scotia held 105,858 shares of ALX Oncology worth $212K as of Q1 2026.
  • Bank of Nova Scotia left its ALX Oncology share count unchanged in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #1024 holding.
  • Bank of Nova Scotia first reported a position in ALX Oncology in Q4 2024 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.